ERBB2 and breast cancer: Furthermore, fascin expression in our BC patients showed significant correlations with poor prognostic features, including the negative status of estrogen receptors (p ≤ 0.0001), progesterone receptors (p = 0.0009), and Her2/neu (p = 0.042).